Clinical Trials

NCT IdNCT04834089
TitleClinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases
ConditionImmunosuppression
StudyTypeInterventional
OrganizationButantan Institute
Sponsor/CollaboratorsButantan Institute
StatusNot yet recruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • Hospital do Rim, Sao Paulo, 04038-002 , Brazil
  • Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, 05403-010 , Brazil
DescriptionPhase I/II Randomized Clinical Trial to evaluate the safety, pharmacokinetic and efficacy of Anti-SARS-CoV-2 hyperimmune serum. The study will include patients at early stage of COVID-19 with increased risk for severe disease due to underlying medical conditions to determine the utility of an equine heterologous serum anti-SARS-CoV-2 to avoid progression to a severe COVID-19